194 related articles for article (PubMed ID: 34244531)
1. Untargeted metabolomics approach to discriminate mistletoe commercial products.
Vanhaverbeke C; Touboul D; Elie N; Prévost M; Meunier C; Michelland S; Cunin V; Ma L; Vermijlen D; Delporte C; Pochet S; Le Gouellec A; Sève M; Van Antwerpen P; Souard F
Sci Rep; 2021 Jul; 11(1):14205. PubMed ID: 34244531
[TBL] [Abstract][Full Text] [Related]
2. Impact of Harvest Conditions and Host Tree Species on Chemical Composition and Antioxidant Activity of Extracts from
Pietrzak W; Nowak R
Molecules; 2021 Jun; 26(12):. PubMed ID: 34205329
[TBL] [Abstract][Full Text] [Related]
3. The Anti-Inflammatory Activity of
Nicoletti M
Plants (Basel); 2023 Mar; 12(7):. PubMed ID: 37050086
[TBL] [Abstract][Full Text] [Related]
4. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
5. Patient' and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment.
Steigenberger C; Schnell-Inderst P; Flatscher-Thöni M; Plank LM; Siebert U
Eur J Oncol Nurs; 2023 Aug; 65():102338. PubMed ID: 37321128
[TBL] [Abstract][Full Text] [Related]
6. Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis.
Vergara-Barberán M; Lerma-García MJ; Nicoletti M; Simó-Alfonso EF; Herrero-Martínez JM; Fasoli E; Righetti PG
J Proteomics; 2017 Jul; 164():52-58. PubMed ID: 28571969
[TBL] [Abstract][Full Text] [Related]
7. Phytochemical screening and effect of Viscum album L. on monoamine oxidase A and B activity and serotonin, dopamine and serotonin receptor 5-HTR1A levels in Galleria mellonealla (Lepidoptera).
Szurpnicka A; Wrońska AK; Bus K; Kozińska A; Jabłczyńska R; Szterk A; Lubelska K
J Ethnopharmacol; 2022 Nov; 298():115604. PubMed ID: 35944736
[TBL] [Abstract][Full Text] [Related]
8. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
Bar-Sela G; Gershony A; Haim N
Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
[TBL] [Abstract][Full Text] [Related]
9. Viscum album L. Therapy in Oncology: An Update on Current Evidence.
Thronicke A; Schad F; Debus M; Grabowski J; Soldner G
Complement Med Res; 2022; 29(4):362-368. PubMed ID: 35325897
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.
Krüerke D; Schenker M; Matter-Walstra K
BMC Complement Med Ther; 2023 Nov; 23(1):395. PubMed ID: 37924102
[TBL] [Abstract][Full Text] [Related]
11. [Mistletoe in the treatment of cancer patients].
Rostock M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):535-540. PubMed ID: 32211937
[TBL] [Abstract][Full Text] [Related]
12.
Melo MNO; Ochioni AC; Zancan P; Oliveira AP; Grazi M; Garrett R; Holandino C; Baumgartner S
Front Pharmacol; 2022; 13():1027931. PubMed ID: 36386174
[No Abstract] [Full Text] [Related]
13. Comprehensive Metabolome Analysis of Fermented Aqueous Extracts of
Peñaloza E; Holandino C; Scherr C; Araujo PIP; Borges RM; Urech K; Baumgartner S; Garrett R
Molecules; 2020 Sep; 25(17):. PubMed ID: 32887375
[TBL] [Abstract][Full Text] [Related]
14. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.
Holandino C; Melo MNO; Oliveira AP; Batista JVDC; Capella MAM; Garrett R; Grazi M; Ramm H; Torre CD; Schaller G; Urech K; Weissenstein U; Baumgartner S
BMC Complement Med Ther; 2020 Jul; 20(1):215. PubMed ID: 32646417
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.
Schad F; Atxner J; Buchwald D; Happe A; Popp S; Kröz M; Matthes H
Integr Cancer Ther; 2014 Jul; 13(4):332-40. PubMed ID: 24363283
[TBL] [Abstract][Full Text] [Related]
16. Adverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer Patients.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Evid Based Complement Alternat Med; 2014; 2014():724258. PubMed ID: 24672577
[TBL] [Abstract][Full Text] [Related]
17. LC-ESI-MS/MS Identification of Biologically Active Phenolic Compounds in Mistletoe Berry Extracts from Different Host Trees.
Pietrzak W; Nowak R; Gawlik-Dziki U; Lemieszek MK; Rzeski W
Molecules; 2017 Apr; 22(4):. PubMed ID: 28417943
[TBL] [Abstract][Full Text] [Related]
18. Phytochemical Profile and Antioxidant Capacity of
Kleszken E; Purcarea C; Pallag A; Ranga F; Memete AR; Miere Groza F; Vicas SI
Plants (Basel); 2022 Nov; 11(22):. PubMed ID: 36432750
[No Abstract] [Full Text] [Related]
19. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
20. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
